These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32736199)

  • 1. Documenting the psychometric properties of the scale for the assessment and rating of ataxia to advance trial readiness of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.
    Bourcier D; Bélanger M; Côté I; Brais B; Synofzik M; Brisson JD; Rodrigue X; Gagnon MM; Mathieu J; Gagnon C
    J Neurol Sci; 2020 Oct; 417():117050. PubMed ID: 32736199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a disease severity index for ataxia of Charlevoix-Saguenay.
    Gagnon C; Brais B; Lessard I; Lavoie C; Côté I; Mathieu J
    Neurology; 2019 Oct; 93(16):e1543-e1549. PubMed ID: 31534027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal Architecture in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): Insights into Disease Pathogenesis and Biomarkers.
    Rezende Filho FM; Bremner F; Pedroso JL; de Andrade JBC; Marianelli BF; Lourenço CM; Marques-Júnior W; França MC; Kok F; Sallum JMF; Parkinson MH; Barsottini OG; Giunti P
    Mov Disord; 2021 Sep; 36(9):2027-2035. PubMed ID: 33893680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement properties of wheelchair use assessment tools in adults with autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Bourassa J; Best KL; Gagnon C; Hébert LJ; Brais B; Routhier F
    Disabil Rehabil Assist Technol; 2022 Nov; 17(8):907-915. PubMed ID: 32981404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and Reliability of Outcome Measures Assessing Dexterity, Coordination, and Upper Limb Strength in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.
    Gagnon C; Lessard I; Brais B; Côté I; Lavoie C; Synofzik M; Mathieu J
    Arch Phys Med Rehabil; 2018 Sep; 99(9):1747-1754. PubMed ID: 29462597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS).
    Hendrickx N; Mentré F; Traschütz A; Gagnon C; Schüle R; ; ; Synofzik M; Comets E
    AAPS J; 2024 Apr; 26(3):57. PubMed ID: 38689016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From motor performance to participation: a quantitative descriptive study in adults with autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Gagnon C; Brais B; Lessard I; Lavoie C; Côté I; Mathieu J
    Orphanet J Rare Dis; 2018 Sep; 13(1):165. PubMed ID: 30231904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsiveness of the Scale for the Assessment and Rating of Ataxia and Natural History in 884 Recessive and Early Onset Ataxia Patients.
    Traschütz A; Adarmes-Gómez AD; Anheim M; Baets J; Brais B; Gagnon C; Gburek-Augustat J; Doss S; Hanağası HA; Kamm C; Klivenyi P; Klockgether T; Klopstock T; Minnerop M; Münchau A; Renaud M; Santorelli FM; Schöls L; Thieme A; Vielhaber S; van de Warrenburg BP; Zanni G; Hilgers RD; ; Synofzik M
    Ann Neurol; 2023 Sep; 94(3):470-485. PubMed ID: 37243847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS): typical clinical and neuroimaging features in a Brazilian family.
    Pedroso JL; Braga-Neto P; Abrahão A; Rivero RL; Abdalla C; Abdala N; Barsottini OG
    Arq Neuropsiquiatr; 2011; 69(2B):288-91. PubMed ID: 21625752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay without Spasticity.
    Aida I; Ozawa T; Fujinaka H; Goto K; Ohta K; Nakajima T
    Intern Med; 2021 Dec; 60(24):3963-3967. PubMed ID: 34121011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing mobility and balance in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay population: Validity and reliability of four outcome measures.
    Lessard I; Brais B; Côté I; Lavoie C; Synofzik M; Mathieu J; Gagnon C
    J Neurol Sci; 2018 Jul; 390():4-9. PubMed ID: 29801904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) - A Polish family with novel SACS mutations.
    Krygier M; Konkel A; Schinwelski M; Rydzanicz M; Walczak A; Sildatke-Bauer M; Płoski R; Sławek J
    Neurol Neurochir Pol; 2017; 51(6):481-485. PubMed ID: 28843771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical presentation and early evolution of spastic ataxia of Charlevoix-Saguenay.
    Duquette A; Brais B; Bouchard JP; Mathieu J
    Mov Disord; 2013 Dec; 28(14):2011-4. PubMed ID: 23913799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography in autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Parkinson MH; Bartmann AP; Clayton LMS; Nethisinghe S; Pfundt R; Chapple JP; Reilly MM; Manji H; Wood NJ; Bremner F; Giunti P
    Brain; 2018 Apr; 141(4):989-999. PubMed ID: 29538656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of autosomal recessive spastic ataxia of Charlevoix Saguenay and spondyloepiphyseal dysplasia in a Turkish patient.
    Kurt S; Kartal E; Aksoy D; Cevik B; Eken AG; Sahbaz I; Nazli Basak A
    J Neurol Sci; 2015 Oct; 357(1-2):290-1. PubMed ID: 26142023
    [No Abstract]   [Full Text] [Related]  

  • 16. Natural History of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay: a 4-Year Longitudinal Study.
    Lessard I; Côté I; St-Gelais R; Hébert LJ; Brais B; Mathieu J; Rodrigue X; Gagnon C
    Cerebellum; 2024 Apr; 23(2):489-501. PubMed ID: 37101017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and reliability of the LEMOCOT in the adult ARSACS population: A measure of lower limb coordination.
    Lessard I; Lavoie C; Côté I; Mathieu J; Brais B; Gagnon C
    J Neurol Sci; 2017 Jun; 377():193-196. PubMed ID: 28477695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis use in patients with Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.
    Beauchesne W; Ouellet-Dupuis F; Frigon MA; Savard C; Gagné-Ouellet V; Gagnon C; Tremblay K
    J Clin Neurosci; 2022 Sep; 103():44-48. PubMed ID: 35809457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel SACS mutation in autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Sánchez MG; Pérez JE; Pérez MR; Redondo AG
    J Neurol Sci; 2015 Nov; 358(1-2):475-6. PubMed ID: 26344561
    [No Abstract]   [Full Text] [Related]  

  • 20. An exploratory natural history of ataxia of Charlevoix-Saguenay: A 2-year follow-up.
    Gagnon C; Lessard I; Lavoie C; Côté I; St-Gelais R; Mathieu J; Brais B
    Neurology; 2018 Oct; 91(14):e1307-e1311. PubMed ID: 30158165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.